{
    "2021-02-17": [
        [
            {
                "time": "2021-01-26",
                "original_text": "Pfizer, BioNTech COVID-19 vaccine likely to protect against South Africa strain",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "BioNTech",
                        "vaccine",
                        "South Africa",
                        "strain"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-01-28",
                "original_text": "Pfizer says South African variant could significantly reduce vaccine protection",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "South African",
                        "variant",
                        "vaccine",
                        "protection"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-01",
                "original_text": "Myovant Sciences and Pfizer Announce Publication in the New England Journal of Medicine of Phase 3 LIBERTY Studies of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids",
                "features": {
                    "keywords": [
                        "Myovant Sciences",
                        "Pfizer",
                        "Phase 3",
                        "LIBERTY",
                        "Relugolix",
                        "Uterine Fibroids"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-05",
                "original_text": "'All stops are going to be pulled outâ€™ once we have the vaccine supply: Fmr. Surgeon General",
                "features": {
                    "keywords": [
                        "stops",
                        "pulled out",
                        "vaccine",
                        "supply",
                        "Surgeon General"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-10",
                "original_text": "Israeli study finds Pfizer vaccine 95% effective against COVID-19",
                "features": {
                    "keywords": [
                        "Israeli",
                        "study",
                        "Pfizer",
                        "vaccine",
                        "effective",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-15",
                "original_text": "President Joe Biden seeks to assuage concerns about pace of vaccination",
                "features": {
                    "keywords": [
                        "President",
                        "Joe Biden",
                        "assuage",
                        "concerns",
                        "vaccination"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-20",
                "original_text": "Exclusive: Pfizer's COVID-19 vaccine supply to the EU 30% below plans - sources",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "vaccine",
                        "supply",
                        "EU",
                        "below plans"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-25",
                "original_text": "Pfizer-BioNTech To Supply Another 200M COVID-19 Vaccine Doses To EU",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "BioNTech",
                        "vaccine",
                        "doses",
                        "EU"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "Imcyse Raises Additional EUR 21.3 Million in Series B Financing Round - Pfizer Joins as Newest Shareholder",
                "features": {
                    "keywords": [
                        "Imcyse",
                        "financing",
                        "Series B",
                        "Pfizer",
                        "shareholder"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-05",
                "original_text": "Europe Calls On Pfizer/BioNtech For 200M More COVID-19 Vaccine Doses",
                "features": {
                    "keywords": [
                        "Europe",
                        "Pfizer",
                        "BioNtech",
                        "vaccine",
                        "doses"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}